Genentech has developed a unique one-armed antibody, onartuzumab, which is now in late-stage clinical trials in multiple cancer types. The company used crystal structures obtained at ALS Beamline 5.0.2 to demonstrate the mechanism of action of this unique potentially therapeutic antibody. Read more »
ALS Work Using Protein Crystallography
Protein crystallography is used for determining the molecular structure of proteins. Crystallized protein molecules cause a beam of incident x-rays to scatter in many directions, with constructive and destructive interference generating a diffraction pattern. By analyzing these patterns, a crystallographer can produce a three-dimensional picture of the density of electrons within the crystal and thus determine the protein's structure.
The Berkeley Center for Structural Biology’s Collaborative Crystallography (CC) program is making major advancements in solving protein structures, especially for users involved in high-throughput projects. The CC program is an NIH-funded, peer-reviewed service that allows external users to apply for both beam time and the support of a crystallographer to perform experiments and subsequent data analyses. Read more »